New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1,3,4-oxadiazole moieties targeting VEGFR: synthesis, in silico studies, and in vitro anticancer assessment
暂无分享,去创建一个
[1] Ammar A. Razzak Mahmood,et al. Design, Synthesis, and Molecular Docking Studies of 5‐Bromoindole‐2‐Carboxylic Acid Hydrazone Derivatives: In Vitro Anticancer and VEGFR‐2 Inhibitory Effects , 2022, ChemistrySelect.
[2] G. Batiha,et al. Computational Study of the Phytochemical Constituents from Uncaria tomentosa Stem Bark against SARS-CoV-2 Omicron Spike Protein , 2022, Journal of Chemistry.
[3] L. Tahtamouni,et al. Synthesis, docking study, and structure activity relationship of novel anti-tumor 1, 2, 4 triazole derivatives incorporating 2-(2, 3- dimethyl aminobenzoic acid) moiety , 2022, Pharmacia.
[4] Abdulrahman M. Saleh,et al. Synthesis, spectroscopic, anti-bacterial activity, molecular docking,ADMET, Toxicity, and DNA binding studies of divalent metal complexes of pyrazole-3-one azo ligand , 2022, Journal of Molecular Structure.
[5] I. Eissa,et al. Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs , 2022, Molecules.
[6] J. Simal-Gándara,et al. Integrated Machine Learning and Chemoinformatics-Based Screening of Mycotic Compounds against Kinesin Spindle ProteinEg5 for Lung Cancer Therapy , 2022, Molecules.
[7] L. Tahtamouni,et al. A novel derivative of picolinic acid induces endoplasmic reticulum stress-mediated apoptosis in human non-small cell lung cancer cells: synthesis, docking study, and anticancer activity , 2021, Pharmacia.
[8] M. Elsohly,et al. Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluation. , 2021, Bioorganic chemistry.
[9] Ammar I. Al-Bayati,et al. Synthesis, docking study, and in vitro anticancer evaluation of new flufenamic acid derivatives , 2021 .
[10] H. Alkahtani,et al. New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. , 2021, Bioorganic chemistry.
[11] M. Alanazi,et al. Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers , 2021, Journal of enzyme inhibition and medicinal chemistry.
[12] I. Eissa,et al. Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors , 2019, Archiv der Pharmazie.
[13] M. Ohira,et al. Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status , 2019, International journal of oncology.
[14] V. Kulkarni,et al. Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective , 2019, Medicine in Drug Discovery.
[15] M. Ohba,et al. Receptor Tyrosine Kinase-Targeted Cancer Therapy , 2018, International journal of molecular sciences.
[16] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[17] Seong-ho Lee,et al. Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review. , 2018, Current medicinal chemistry.
[18] J. Duyster,et al. Anti-Angiogenics: Current Situation and Future Perspectives , 2018, Oncology Research and Treatment.
[19] Yonghe Li,et al. Synthesis and preliminary assessment of the anticancer and Wnt/β-catenin inhibitory activity of small amide libraries of fenamates and profens , 2017, Medicinal Chemistry Research.
[20] R. Basha,et al. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution. , 2016, The Journal of nutritional biochemistry.
[21] A. Mansour,et al. Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents , 2016, Scientific Reports.
[22] R. Lencioni,et al. Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma , 2014, Hepatology.
[23] S. Safe,et al. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors , 2014, Molecular carcinogenesis.
[24] B. Han,et al. The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib , 2012, Acta Pharmacologica Sinica.
[25] B. Sripanidkulchai,et al. Evaluation of the anticancer potential of six herbs against a hepatoma cell line , 2012, Chinese Medicine.
[26] Y. S. Shin,et al. Tolfenamic Acid Induces Apoptosis and Growth Inhibition in Head and Neck Cancer: Involvement of NAG-1 Expression , 2012, PloS one.
[27] Hua Wang,et al. Role of death receptor, mitochondrial and endoplasmic reticulum pathways in different stages of degenerative human lumbar disc , 2011, Apoptosis.
[28] R. Basha,et al. Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors. , 2011, Gynecologic oncology.
[29] S. Fulda,et al. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy , 2006, Oncogene.
[30] K. Shikha,et al. Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2-[(2,6-dichloroanilino) phenyl]acetic acid derivatives. , 2004, European journal of medicinal chemistry.
[31] N. Ferrara. Role of vascular endothelial growth factor in the regulation of angiogenesis. , 1999, Kidney international.
[32] M. Shibuya,et al. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. , 2013, Journal of biochemistry.